Exponent (EXPO) is back in focus after reporting first quarter 2026 results, with double digit growth in revenue and earnings, updated leadership roles, and fresh capital return moves through dividends and buybacks.

Despite the upbeat first quarter story around AI related consulting work, utilities risk management, dividends, and buybacks, Exponent’s recent share price performance has been subdued, with a 90 day share price return of 9.17% and a 1 year total shareholder return of 13.59%.

If this mix of earnings updates and changing expectations has you reassessing your watchlist, it can be helpful to see what else is moving in related areas such as robotics and automation through 32 robotics and automation stocks.

So with Exponent delivering double digit growth, a higher dividend and buyback capacity, yet a 1 year total shareholder return decline of 13.59%, are you looking at an undervalued specialist, or is the market already pricing in future growth?

Most Popular Narrative: 27.5% Undervalued

At a last close of $65.28 versus a narrative fair value of $90, Exponent is framed as meaningfully undervalued, with that gap tied to future earnings power and cash flow strength.

Ongoing expansion into high-growth, innovation-driven domains, including artificial intelligence safety, distributed energy systems, and advanced medical technologies, broadens Exponent's addressable market and client base, setting up an accelerating revenue trajectory as these industries scale.

Strengthening headcount growth, propelled by effective recruiting and a development-focused culture, enables Exponent to capture more project volume and maintain its reputation-driven pricing power, with positive implications for both top-line growth and sustained high net margins.

Want to see what turns that earnings story into a $90 fair value? The narrative leans on measured growth, sticky margins, and a premium multiple that stands out.

Result: Fair Value of $90 (UNDERVALUED)

However, flat net revenues, combined with EBITDA and margin pressure, along with lower utilization and headcount efficiency, could challenge the premium earnings narrative investors are weighing.

Another View: High P/E Puts a Question Mark on “Cheap”

Our DCF work frames Exponent as trading 44.7% below an estimated cash flow value of $118.08, which points firmly to undervaluation. Yet the current 29.5x P/E is far above the US Professional Services industry at 19.6x and the 18.2x fair ratio. This raises the question of whether the share price is really cheap, or merely appears cash flow friendly on paper.

Next Steps

Does this mix of potential and concern leave you on the fence? Act while the details are fresh and weigh both sides with 5 key rewards and 1 important warning sign

Looking for more investment ideas?

Exponent may sit near the top of your list today, but casting a wider net with clear, data driven filters can surface opportunities you might otherwise miss.

• Target dependable income and stability by reviewing companies we highlight as potential 13 dividend fortresses.
• Hunt for quality at a sensible price by scanning companies flagged as 51 high quality undervalued stocks.
• Prioritise resilience by focusing on businesses surfaced in our 67 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.